Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Rheum Dis ; 73(3): 624-7, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24257024

ABSTRACT

OBJECTIVES: Canonical as well as non-canonical Wnt signalling pathways have emerged as core pathways of fibrosis. Their profibrotic effects are mediated via distinct intracellular cascades independently of each other. Thus, inhibition of both pathways may have additive antifibrotic effects. Here, we knocked down evenness interrupted (EVI) to simultaneously target for the first time canonical and non-canonical Wnt signalling in experimental fibrosis. METHODS: The antifibrotic effects of siRNA-mediated knockdown of EVI were evaluated in the mouse models of bleomycin-induced skin fibrosis and in fibrosis induced by adenoviral overexpression of a constitutively active TGF-ß receptor I (AdTBRI). RESULTS: Knockdown of EVI decreased the release of canonical and non-canonical Wnt ligands by fibroblasts and reduced the activation of canonical and non-canonical Wnt cascades in experimental fibrosis with decreased accumulation of ß-catenin and phosphorylated JNK and cJun. Inactivation of EVI exerted potent antifibrotic effects and reduced dermal thickening, myofibroblast differentiation and accumulation of collagen in the mouse models of bleomycin-induced and AdTBR-induced fibrosis. CONCLUSIONS: Inhibition of Wnt secretion by knockdown of EVI inhibits canonical and non-canonical Wnt signalling and effectively reduces experimental fibrosis in different preclinical models. Inhibition of Wnt secretion may thus be an interesting approach for the treatment of fibrosis.


Subject(s)
Fibroblasts/metabolism , Intracellular Signaling Peptides and Proteins/genetics , Receptors, G-Protein-Coupled/genetics , Scleroderma, Systemic/prevention & control , Skin/pathology , Wnt Signaling Pathway/genetics , Animals , Cells, Cultured , Disease Models, Animal , Fibrosis , Gene Knockdown Techniques , Genetic Therapy/methods , Humans , Intracellular Signaling Peptides and Proteins/physiology , MAP Kinase Kinase 4/metabolism , Mice , Phosphorylation , Proto-Oncogene Proteins c-jun/metabolism , RNA, Small Interfering/genetics , Receptors, G-Protein-Coupled/physiology , Scleroderma, Systemic/genetics , Scleroderma, Systemic/metabolism , Scleroderma, Systemic/pathology , Wnt Signaling Pathway/physiology , beta Catenin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...